Indirect inhibition of NLRP3 inflammasome activation in 3 × TgAD mice using the fenamate non-steroidal anti-inflammatory drug, mefanamic acid, completely abrogated the AD-related neuroinflammation, with levels of IL-1β expression and microglial activation reduced to wild-type levels. This evidence concerns the gene IL1B and Alzheimer disease.